Bladder drug tested to fire up Body's Calorie-Burning fat
NCT ID NCT03049462
Summary
This early-stage study is exploring whether a drug called mirabegron can activate the body's 'brown fat,' a special type of fat that burns calories. Researchers want to see if this activation can improve how the body uses insulin and manages energy in adults, including some women with Polycystic Ovary Syndrome (PCOS). Participants will take the drug or a placebo for four weeks while undergoing detailed scans and metabolic tests to measure changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.